RedHill Biopharma (RDHL) Inventory (2017 - 2025)

RedHill Biopharma (RDHL) has 9 years of Inventory data on file, last reported at $3.2 million in Q2 2025.

• Inventory for Q2 2025 came in at $3.2 million, down 16.69% year-over-year; the trailing twelve-month figure through Jun 2025 was $3.2 million (down 16.69% YoY), and the FY2024 annual result was $3.7 million, down 16.81% from the prior year.
• Inventory retreated to $3.2 million in Q2 2025 per RDHL's latest filing, from $3.7 million in the prior quarter.
• Over five years, Inventory peaked at $14.3 million in Q1 2022 and troughed at $3.2 million in Q2 2025.
• A 5-year average of $8.2 million and a median of $8.2 million in 2021 frame the typical range for Inventory.
• The sharpest annual moves came in 2021 and 2023: Inventory surged 235.02% in 2021, then slumped 60.13% in 2023.
• A 5-year view of Inventory shows it stood at $7.7 million in 2021, then jumped by 42.97% to $11.0 million in 2022, then tumbled by 60.13% to $4.4 million in 2023, then retreated by 16.81% to $3.7 million in 2024, then slipped by 13.2% to $3.2 million in 2025.
• Business Quant data shows RDHL's Inventory at $3.2 million in Q2 2025, $3.7 million in Q4 2024, and $3.8 million in Q2 2024.